ArticleNature communications2025

CD248-targeted BBIR-T cell therapy against late-activated fibroblasts in cardiac repair after myocardial infarction.

Haiting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.